Development of tumor immunotherapy by vaccinated cancer cells
Development of tumor immunotherapy by vaccinated cancer cells
批准号:
05671655
负责人:
UMEZU Yasuiki
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The immunogenicity of human cancer cells is generally very low. Poorly immunogenic animal tumor cells can be converted into highly immunogenic tumors by several techniques. The purpose of this studies is to investigate whether UV-B-irradiated, IL-2 genetransduced, or IL-12 genetransduced human cancer cells are more immunogenic than untreated tunor cells with respect to MHC antigen expression, and the ability of inducing cytotoxic T lymphocyte (CTL) activity. UV-B radiation respectively decreased or increased MHC class I expression of freshly isolated tumor cells or cultured tumor cells, and also decreased MHC class I expression of starved cultured tumor cells. It increased the ability of both freshly isolated and cultured tumor cells to induce CTL activity from PBMC against untreated autologous tumor cells. These results indicated that UV radiation increased the ability of tumor cells to induce CTL activity without a corresponding effect on MHC antigen expression. Human renal cell carc … More inoma (RCC) cells transduced with human IL-2 gene (RCC-IL-2) stimulated PBMC to demonstrate LAK activity, and also stimulated autologous TILs to proliferate and exhibit cytotoxicity relatively restricted to autologous tumor cells. In contrast, both parental RCC and RCC transduced with neomycin gene alone failed to induce these activities. These results indicate that RCC-IL-2 cells are more potent than the other RCC cells with regard to inducing cytotoxic lymphocytes against autologous tumor cells. IL-12 genetransduced squamous cell carcinoma (IL-12-SCC) cells displayd enhanced expression of MHC class I antigen to induce autologous CTL against autologous SCC cells more potently than parental, non-IL-12 gene-transduced SCC cells. The main effector cells that exhibited relatively specific cytolysis against parental SCC cells were CD16+CD56+cells. In addition IL-12 gene-SCC cells were more susceptible to those effector cells than parental SCC cells. These results suggest that IL-12 may be able to maintain NK-cells for a long -term to display major, specific cytotoxicity and IL-12-SCC cells are well-recognized to lyse by those effector cells. In summary, UV radiation, IL-2, or IL-12 gene-transduction are potent methods to change tumor cells to induce CTL,or activated NK-cells with or without a corresponding effects on MHC antigen expression. Less
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kyogi ITOH: "Increase capability of Interleukin 2gene-Transduced Renal Cell earcinoms cells induce cytotoxic Lymphocytes21GC01:The Kurume Medical Journal" 41. 53-63 (1994)
Kyogi ITOH:“增加白细胞介素 2 基因转导的肾细胞癌细胞诱导细胞毒性淋巴细胞的能力21GC01:久留米医学杂志”41. 53-63 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yasuiki Umezu: "Characterization of IL-12 induced effector cells and augmentaton of Susceptibility of tumor cells to effector cells by IL-12gene-Transduction" Cancer Res. (発表予定).
Yasuiki Umezu:“IL-12 诱导效应细胞的表征以及通过 IL-12 基因转导增强肿瘤细胞对效应细胞的敏感性”Cancer Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yasuiki Umezu.: "Increase in the ability of human cancer cells toinduce cytotoxic T Lymphocytes by ultravidet irradiation." Cancer Immunology Immunotherapy. 37. 392-399 (1993)
Yasuiki Umezu.:“通过紫外线照射增强人类癌细胞诱导细胞毒性 T 淋巴细胞的能力。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yasuiki Umezu: "Characteri zation f IL-12 induced effector cells and augmentation of susceptibility of tumor cells to effector cells by IL-12 gene-transduction." in preparation for Cancer Res.
Yasuiki Umezu:“IL-12 诱导效应细胞的表征以及通过 IL-12 基因转导增强肿瘤细胞对效应细胞的敏感性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kyogo Itoh: "Increase in the Capabitity of Interleukin 2 Gene-Transduced Kanal Cell Carcinoma Cells to induce Cytotoxic Lymphocytes." The KURUME MEDICAL JOURNAL. Vol41. 53-63 (1994)
Kyogo Itoh:“增加白细胞介素 2 基因转导的 Kanal 细胞癌细胞诱导细胞毒性淋巴细胞的能力。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Analysis of MHC-restricted tumor rejection antigen induced by IL-12.
-
批准号:11671973
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:1999
-
负责人:UMEZU Yasuiki
-
依托单位:
海外基金